Cleared Traditional

K241334 - Semi-Floating Temporary Pacing Electrode Catheter, Bipolar, Stainless Steel Electrodes, 115 cm, 4Fr. (006221P) (FDA 510(k) Clearance)

Also includes:
Semi-Floating Temporary Pacing Electrode Catheter, Bipolar, Stainless Steel Electrodes, 115 cm, 5Fr. (006225P) Semi-Floating Temporary Pacing Electrode Catheter, Bipolar, Stainless Steel Electrodes, 125 cm, 6Fr. (006241P) Semi-Floating Temporary Pacing Electrode Catheter, Bipolar, Stainless Steel Electrodes, 125 cm, 7Fr. (006242P) NBIH™ Temporary Pacing Electrode Catheter,
Jan 2025
Decision
266d
Days
Class 2
Risk

K241334 is an FDA 510(k) clearance for the Semi-Floating Temporary Pacing Electrode Catheter, Bipolar, Stainless Steel Electrodes, 115 cm, 4Fr. (006221P). This device is classified as a Electrode, Pacemaker, Temporary (Class II - Special Controls, product code LDF).

Submitted by C.R. Bard, Inc. (Covington, US). The FDA issued a Cleared decision on January 31, 2025, 266 days after receiving the submission on May 10, 2024.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.3680.

Submission Details

510(k) Number K241334 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 10, 2024
Decision Date January 31, 2025
Days to Decision 266 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code LDF — Electrode, Pacemaker, Temporary
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.3680

Similar Devices — LDF Electrode, Pacemaker, Temporary

Bard® Temporary Pacing Electrode Catheter Needle / Cannula (Introducer)
K251186 · C.R. Bard, Inc. · May 2025
Streamline Unipolar Pediatric Temporary Pacing Lead (6491) Streamline Unipolar Temporary Atrial Pacing Lead (6492) Streamline Unipolar Temporary Myocardial Pacing Wire (6494) Streamline Bipolar Temporary Myocardial Pacing Lead (6495) Streamline Unipolar Temporary Myocardial Pacing Lead (6500)
K242705 · Medtronic, Inc. · Jan 2025